Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients

Continuous subcutaneous (SubQ) treprostinil is an effective therapy for pediatric patients diagnosed with pulmonary hypertension (PH). To date, the clinical characteristics and factors associated with failure to tolerate this therapy have not been described. The purpose was to describe patient‐repor...

Descripción completa

Detalles Bibliográficos
Autores principales: McSweeney, Julia, Colglazier, Elizabeth, Becerra, Jasmine, Leary, Brienne, Miller‐Reed, Kathleen, Walker, Stephen, Tillman, Katy, Magness, Melissa, Ogawa, Michelle, Bannon, Whitney, Kivett, Tisha, Jackson, Emma O., Davis, Anne, Shepard, Cathy, Richards, Susan, Whalen, Elise, Engstrand, Shannon, DiPasquale, Zachary, Connor, Jean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151594/
https://www.ncbi.nlm.nih.gov/pubmed/37143765
http://dx.doi.org/10.1002/pul2.12224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151594/
https://www.ncbi.nlm.nih.gov/pubmed/37143765
http://dx.doi.org/10.1002/pul2.12224

Ejemplares similares